Rakuten Investment Management Inc. lessened its holdings in shares of Cencora, Inc. (NYSE:COR – Free Report) by 54.7% in the 4th quarter, HoldingsChannel.com reports. The firm owned 25,094 shares of the company’s stock after selling 30,348 shares during the quarter. Rakuten Investment Management Inc.’s holdings in Cencora were worth $8,538,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently made changes to their positions in COR. United Bank lifted its holdings in shares of Cencora by 4.5% during the 2nd quarter. United Bank now owns 7,032 shares of the company’s stock valued at $2,109,000 after purchasing an additional 305 shares during the last quarter. Nebula Research & Development LLC purchased a new stake in shares of Cencora during the 2nd quarter valued at $595,000. Treasurer of the State of North Carolina lifted its holdings in shares of Cencora by 7.9% during the 2nd quarter. Treasurer of the State of North Carolina now owns 85,534 shares of the company’s stock valued at $25,647,000 after purchasing an additional 6,244 shares during the last quarter. Diversify Advisory Services LLC lifted its holdings in shares of Cencora by 94.1% during the 2nd quarter. Diversify Advisory Services LLC now owns 2,585 shares of the company’s stock valued at $747,000 after purchasing an additional 1,253 shares during the last quarter. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main lifted its holdings in shares of Cencora by 26.0% during the 2nd quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 73,452 shares of the company’s stock valued at $22,025,000 after purchasing an additional 15,154 shares during the last quarter. Hedge funds and other institutional investors own 97.52% of the company’s stock.
Wall Street Analyst Weigh In
COR has been the subject of several analyst reports. William Blair initiated coverage on Cencora in a report on Tuesday, April 28th. They set a “market perform” rating for the company. UBS Group increased their price objective on Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a report on Thursday, May 7th. Evercore set a $360.00 price objective on Cencora in a report on Wednesday, April 8th. Leerink Partners restated an “outperform” rating on shares of Cencora in a research note on Tuesday, March 17th. Finally, Weiss Ratings lowered Cencora from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, May 22nd. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, Cencora has a consensus rating of “Moderate Buy” and an average price target of $374.00.
Cencora Stock Performance
Shares of COR stock opened at $281.22 on Wednesday. The firm has a market capitalization of $54.71 billion, a price-to-earnings ratio of 21.57, a price-to-earnings-growth ratio of 1.52 and a beta of 0.59. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59. The business has a fifty day moving average of $287.49 and a 200 day moving average of $326.05. Cencora, Inc. has a 1 year low of $244.82 and a 1 year high of $377.54.
Cencora (NYSE:COR – Get Free Report) last issued its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). The firm had revenue of $78.36 billion during the quarter, compared to analysts’ expectations of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.The business’s revenue was up 3.9% on a year-over-year basis. During the same quarter last year, the business earned $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, research analysts expect that Cencora, Inc. will post 17.79 earnings per share for the current year.
Cencora Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were paid a dividend of $0.60 per share. The ex-dividend date was Friday, May 15th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.9%. Cencora’s dividend payout ratio (DPR) is presently 18.40%.
Cencora declared that its board has authorized a share buyback plan on Thursday, May 21st that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the company to buy up to 3.9% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s board believes its stock is undervalued.
Cencora Company Profile
Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.
Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.
Further Reading
- Five stocks we like better than Cencora
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Want to see what other hedge funds are holding COR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cencora, Inc. (NYSE:COR – Free Report).
Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.
